INSIGHTS ON LIQUID DOSE MANUFACTURING
-
EU GMP-Annex 1: Changes, Challenges, And Ready-To-Use Sterile Packaging
Leveraging a pre-sterilized containment solution that meets the requirements of Annex 1 and outsources non-core activities can help prevent contamination and reduce the effort and liability of the CCS.
-
Pioneering Precision In Pharma And Radiopharma Solutions
Discover a company that delivers innovative pharmaceutical production solutions and specializes in Radiopharmaceuticals, Cell and Gene Therapy, and traditional drugs with precision-engineered, integrated systems.
-
Finding The Right Aseptic Processing Approach
How should you approach building your aseptic processing line? Gain insight into the advantages of using a modular, configurable technology rather than custom fill-finish solutions.
-
Delivering Innovative Solutions & Relied Upon Turn-Key Systems
Explore advanced aseptic fill-finish automation, modular isolation systems, and the technical drivers behind out-of-nest processing for ready-to-use containers.
-
UPLC Columns: Fundamentals, Chemistries, And Selected Small-Molecule Applications10/11/2024
Discover the fundamentals of UPLC columns and their diverse chemistries. Learn more about versatility in separating small-molecule analytes using reversed-phase and hydrophilic interaction techniques.
-
Accelerating Sterile Injectable Innovation Through Strategic Outsourcing9/21/2025
Sterile injectables are vital for modern medicine. Learn how outsourcing manufacturing to a CDMO can accelerate development and commercialization.
-
Fluid Management Strategies For Scalable Biopharmaceutical Production4/16/2025
Effective fluid management systems are indispensable in therapeutic manufacturing. Discover how modular design, automation, and single-use systems enhance scalability and maintain product integrity.
-
Drug Substance To Fill-Finish Handoff: What Sponsors Need To Know5/14/2026
Effective drug substance handoff to fill-finish manufacturing depends on early collaboration, clear communication, and proactive planning to reduce risks, ensure quality, and maintain timelines.
-
Navigating Sterile Injectable CMO Selection: A Technical And Quality Assessment6/11/2025
Learn how to carry out an effective technical and quality assessment and what specific criteria to prioritize when selecting a sterile injectable CMO partner.
LIQUID DOSE MANUFACTURING SOLUTIONS
-
When you need to provide a clean, contained environment for the safe handling of powders in dispensing, weighing, sampling, or subdivision operations, our PharmAir booths are a highly effective option. Complete containment solutions based around an innovative range of Downflow Containment Booths that bring different features and benefits to your application. But all have one thing in common: they give a Guaranteed Working Environment.
-
BoMa systems allow transferring and dosing products with a complex rheology, in particular products of high viscosity. The absence of rotating seals is ideal for its use for aggressive or flammable products.
-
The Aseptic Filling Isolator is a custom-designed cGMP Class A/ISO 5 isolator system specifically designed for batch scale pharmaceutical production of injectable products for pre-clinical and clinical trial studies.
-
AST aseptic filling products address the unique processing requirements of biologics manufacturing to gently care for biologic products during the fill-finish process. Their highly accurate peristaltic dosing system uses single-use pharmaceutical grade tubing that has been optimized to keep shear stress to an absolute minimum. When exiting the fluid path through the filling needle, the motion control system maintains the fill needle within the container and slowly rises as the product is being dispensed to minimize splashing and foaming that could introduce stress to the product. Temperature controlled filling is also possible with the ASEPTiCell® and GENiSYS® systems. AST has experience dosing products at temperatures as low as 3°C.
-
Advanced lipid nanoparticle strategies are transforming RNA therapeutics by enabling faster optimization, precise tissue targeting, and access to biological targets once considered unreachable.